OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ACTJ.J54

Afrocentric Investment Corporation Ltd

ReinsuranceVerified

Afrocentric Investment Corporation Ltd has a fully diluted share count of 817,628,945, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Afrocentric Investment Corporation Ltd, as no financial data has been provided for comparison against industry benchmarks. This lack of data limits the ability to assess the company's performance relative to its peers. Segment and geographic exposure details are not disclosed in the available data, making it difficult to evaluate the company's revenue concentration or geographic diversification. Growth trajectory data is not available for Afrocentric Investment Corporation Ltd, as no outlook or revenue history has been provided. This limits the ability to assess the company's future performance or growth potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. The company is currently assessed as having low dilution risk, with no dilution potential from basic shares outstanding. Recent events or filings are not disclosed in the available data, limiting the ability to assess the company's recent performance or strategic direction.

30-day price · ACTJ.J+50.00 (+71.4%)
Low$70.00High$142.00Close$120.00As of15 May, 00:00 UTC
Profile
CompanyAfrocentric Investment Corporation Ltd
TickerACTJ.J
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryReinsurance
AI analysis

Business. Afrocentric Investment Corporation Ltd operates in the reinsurance industry, providing insurance-related financial services to clients.

Classification. The company is classified under the Reinsurance industry within the Insurance business sector and Financials economic sector, with a confidence level of 0.92.

Afrocentric Investment Corporation Ltd has a fully diluted share count of 817,628,945, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Afrocentric Investment Corporation Ltd, as no financial data has been provided for comparison against industry benchmarks. This lack of data limits the ability to assess the company's performance relative to its peers. Segment and geographic exposure details are not disclosed in the available data, making it difficult to evaluate the company's revenue concentration or geographic diversification. Growth trajectory data is not available for Afrocentric Investment Corporation Ltd, as no outlook or revenue history has been provided. This limits the ability to assess the company's future performance or growth potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. The company is currently assessed as having low dilution risk, with no dilution potential from basic shares outstanding. Recent events or filings are not disclosed in the available data, limiting the ability to assess the company's recent performance or strategic direction.
Key takeaways
  • Afrocentric Investment Corporation Ltd operates in the reinsurance industry with a fully diluted share count of 817,628,945.
  • The company's liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • No financial data is available to assess profitability or return metrics against industry benchmarks.
  • Growth trajectory and revenue history are not disclosed, limiting the ability to evaluate future performance.
  • The company is assessed as having low dilution risk, with no dilution potential from basic shares outstanding.
  • Recent events or filings are not disclosed, limiting the ability to assess the company's recent performance or strategic direction.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyZAR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$8.07B$734.0M$302.0M$339.9M
FY-3$8.69B$724.2M$312.8M$563.9M
FY-2$8.76B$482.0M$183.5M$394.5M
FY-1$4.24B-$37.0M-$125.9M
FY0$7.30B-$517.2M-$1.27B-$472.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$5.11B$2.33B$198.9M
FY-3$5.44B$2.45B$138.6M
FY-2$5.56B$3.44B$189.8M
FY-1$5.16B$3.25B
FY0$4.18B$1.90B
PeriodOCFCapExFCFSBC
FY-4$385.3M-$493.8M$339.9M
FY-3$527.0M-$303.7M$563.9M
FY-2$381.7M-$258.4M$394.5M
FY-1$249.3M-$134.9M
FY0$684.9M-$219.3M-$472.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Insurance · cohort 5 companies
MetricACTJ.JActivity
Op margin19.9% medp25 18.5% · p75 33.1%
Net margin13.0% medp25 12.2% · p75 21.2%
Gross margin63.2% medp25 34.2% · p75 67.3%
CapEx / revenue-1.6% medp25 -2.7% · p75 -0.1%
Debt / equity4.8% medp25 0.3% · p75 25.4%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-09 03:52 UTC#e5c2f8c7
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 06:28 UTCJob: ca837cc3